Wall Street brokerages expect that Inspire Medical Systems, Inc. (NYSE:INSP – Get Rating) will report ($0.73) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Five analysts have issued estimates for Inspire Medical Systems’ earnings, with estimates ranging from ($0.90) to ($0.47). Inspire Medical Systems posted earnings of ($0.60) per […]
Markets
In a report issued on April 26, Richard Newitter from Leerink Partners maintained a Buy rating on Inspire Medical Systems (INSP – Research Report). The company’s shares closed last Wednesday at $242.23, close to its 52-week high of $252.25.
According to TipRanks.com, Newitter is a 5-star analyst with an average return of 28.6% and a 71.1% success rate. Newitter covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Organogenesis Holdings, and Intuitive Surgical.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Inspire Medical Systems with a $257.00 average price target, implying a 9.1% upside from current levels. In a report issued on April 22, Robert W. Baird also maintained a Buy rating on the stock with a $260.00 price target.